The largest database of trusted experimental protocols

Ap20187

Manufactured by Takara Bio
Sourced in United States

The AP20187 is a laboratory equipment product manufactured by Takara Bio. It serves as a core component for various research applications. The product specifications and technical details are available upon request.

Automatically generated - may contain errors

53 protocols using ap20187

1

Oligomerization of YFP/TDP-43 with AP20187

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligomerization of YFP or TDP-43 was achieved by the addition of AP20187 (Clontech, 635059) into the culture medium of transfected cells at 0.5 μM otherwise mentioned, and the cells were incubated in the presence of AP20187 for the indicated time period.
+ Open protocol
+ Expand
2

Inducible Dimerization of EpoR for Erythropoiesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The homodimer system (Takara, Japan) containing the chemical inducer of dimerization (CID, also called AP20187 or B/B Homodimerizer) and the pHom-Mem1 plasmid were purchased [18 (link)]. The intracellular domain of EpoR cDNA (247–406 amino acids) [23 (link)] was fused to GFP cDNA (pEGFP-N1; Takara), and the EpoR-GFP cDNA was inserted into the pHom-Mem1 plasmid containing a myristoylation signal peptide and the cDNA encoding the CID-binding protein (DmrB). The resulting product was ligated to a mouse Gata1 genomic fragment (GIHRD) spanning from 3.9 kb upstream of the first exon (IE exon) to the second exon [21 (link)]. The transgenic construct was referred to as G1HRD-idEpoRic (inducible dimerization of EpoR intracellular domain) and injected into fertilized eggs from BDF1 parents (CREA Japan). All mice were genotyped by PCR amplification of the GFP gene [25 (link)]. CID (10 mg/kg) and rHuEPO (300 U/kg; Chugai Pharmaceutical, Japan) were administered intraperitoneally. For oral administration, CID (100 mg/kg) was diluted with 50% PEG400 (Wako, Japan) in saline and immediately administered using a gastric tube. More than 3 mice or embryos in each experimental group were used in every experiment.
+ Open protocol
+ Expand
3

Chemogenetic and Optogenetic Cell Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The designer receptor-expressing cells were washed three times by PBS, then cultured in the medium without IL-3 for 5 h before stimulation. The cells (1.0 × 106 cells) were collected in a microtube by centrifugation at 380 g. For chemical stimulation, 500 μl of RPMI medium supplemented with 50 nM AP20187 (Takara Bio) was mixed with the cells pellet, then keep at 37°C for 15 min. For light stimulation, cells were exposed with 450 nm blue light at 0.5 mW/cm2 at 37 °C for appropriate time periods.
+ Open protocol
+ Expand
4

Viability Assay of Gene-Modified Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Viability assays were performed to assess the ablation of gene-modified cells in vitro. For that, 1 ∗ 104 (iC9) or 5 ∗ 103 (TK.007) transgenic cells were seeded per well onto white opaque 96 well plates coated with Geltrex (Gibco). The next day, the cultures were treated with different concentrations of GCV (InvivoGen, San Diego, CA, USA), AP20187 (Takara, Saint-Germain-en-Laye, France) or vehicle (0.9% NaCl or 0.4% ethanol). GCV-treated cells were incubated for 5 days prior to final readout, whereas AP20187 treated cells were analyzed 24 h post-drug-administration using the CellTiterGlo® 2.0 cell viability assay (Promega, Mannheim, Germany) and the TriStar2 S LB 942 multimode microplate reader (Berthold, Bad Wildbad, Germany) or SpectraMax®ParadigmTM Multi-Mode Microplate detection platform (Beckmann Coulter).
+ Open protocol
+ Expand
5

Intramuscular Delivery of Liposomes and Homodimerizer Compounds in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
AP20187 (B/B Homodimerizer, Takara Bio USA) was dissolved in 100% ethanol to form a stock solution at a concentration of 62.5 mg/ml and stored at −20 °C. A dosing solution of 10 mg/kg active drug was prepared from stock solution, PEG-400 (100%), and Tween (2%) per manufacturer instructions. A solution (vehicle control) containing of ethanol, PEG-400 (100%), and Tween (2%) was prepared similarly. AP20187 or vehicle control were dosed at 2 μl solution/g mouse per leg (5 μg/g AP20187). The dosing solutions were used within 30 min of preparation.
Liposomes were stored at 4 °C. Prior to injection, the clodronate-containing liposomes (5 mg/ml) and PBS-containing liposomes (vehicle control) were removed from the refrigerator and allowed to acclimate to room temperature (18 °C). The tubes containing liposomes were inverted 8–10 times to ensure even distribution. Liposomes were dosed at 20 μl of solution per leg (100 μg clodronate). In the ALI mouse model, mice were injected 1 day before and 1 day following lung injury.
The mouse fur was removed from bilateral lower limbs overlying the tibialis anterior (TA) muscle compartment. Skin was cleaned with 70% ethanol and the dosing solution injected in four aliquots along the body of the TA muscle compartment, as previously described (Files et al., 2012 (link)).
+ Open protocol
+ Expand
6

Macrophage Depletion in MaFIA Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrophages were ablated in male C57BL/6-Tg(Csf1r-EGFP-NGFR/FKBP1A/TNFRSF6)2Bck/J mice, also known as macrophage Fas Ligand-induced apoptosis (MaFIA) mice (Jackson Strain #005070). MaFIA mice (10–12 weeks old) were treated with 5mg/kg AP20187 (Takara Bio USA) in 1% DMSO + 10% PEG-400 + 2% Tween-80 in sterile water daily for 3 days, then every other day through the end of the study to induce dimerization of Fas and subsequent apoptosis in colony stimulating factor 1 receptor promoter (Csf1r)-expressing cells [49 (link)]. Untreated age-and sex-matched MaFIA mice were used as controls.
+ Open protocol
+ Expand
7

Generating Fibroblast-Depleted Micropatterned PHH Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PHH co-culture with murine embryonic fibroblasts 3T3-J2s were generated by seeding cryopreserved primary human hepatocytes purchased from BioIVT on collagen-patterned 96-well plates as described previously (Khetani and Bhatia, 2008 (link); March et al., 2015 (link)). 3T3-J2s were a kind gift provided by Howard Green, Harvard Medical School. Fibroblast-depleted micropatterned PHH cultures were obtained by incorporation of 3T3-J2s expressing an inducible apoptosis switch (inducible caspase-9 [Casp9]). 3T3-J2s were lentivirally transduced with the pMSCV-F-del Casp9.IRES.GFP plasmid (15567, Addgene) followed by FACS purification (top 15%, FACSAria II, BD Biosciences) (Chen et al., 2020 (link)). On the day of infection, PHH co-cultures were dosed with a chemical inducer of dimerization (0.5 μM AP20187, Takarabio) to trigger fibroblast removal via apoptosis. PHH co-cultures were maintained in Dulbecco’s modified Eagle’s medium (DMEM, Corning) supplemented with 10% fetal bovine serum (Gibco), 1% insulin/transferrin/selenous acid and linoleic acid (ITS; BD Biosciences), 7 ng/mL glucagon (Sigma-Aldrich), 40 ng/mL dexamethasone (Sigma-Aldrich), 15 mM HEPES (Gibco), and 100 μg/mL penicillin-streptomycin (Corning). Cells were kept at 37C with 5% CO2. Donors utilized in this study are labeled as donor A and donor B.
+ Open protocol
+ Expand
8

Cell Viability Assay with AP20187

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed with PBS twice and seeded into 24-well plates in the culture medium containing various concentrations of AP20187 (TakaraBio), 1 ng/mL of IL-3 (ThermoFisher Scientific), or 10 ng/mL of G-CSF (R&D Systems). Viable cell densities were estimated by Cell Counting Kit-8 (Dojindo Laboratories) by measuring absorbance at 450 nm using GloMax Discover Microplate Reader (Promega).
+ Open protocol
+ Expand
9

Podocyte Apoptosis Induction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Littermates of 8–12 weeks of age received doxycycline hyclate (0.2 mg/ml; Sigma) for 3 weeks in drinking water, followed by 1 day of normal water prior to induction of kidney injury. To activate Caspase‐8 driven apoptosis in podocytes, the dimerizer agent AP20187 was prepared according to the manufacturer's recommendation (Takara Bio USA, Inc.) and injected intraperitoneally at a dose of 0.4 µg/g body weight. All mice received a dimerizer injection. Injury was confirmed in POD+mice with observation of ascites at 2–3 days post‐injury (Rutkowski et al., 2013 (link)).
+ Open protocol
+ Expand
10

Generation of Optimized CLL-1 CAR T-cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A CLL-1 CAR previously described by our group19 (link) was modified using in-Fusion Cloning (Takara/Clontech, California, USA) to generate a panel of CLL-1 CARs with altered spacer, transmembrane and costimulatory domains. Retroviral vector production and T cell transduction have been described previously.19 (link) CAR T-cells were expanded in complete medium (45% RPMI 1640; Hyclone, Waltham, Massachusetts, USA), 45% Click’s media (Irvine Scientific, Santa Ana, California, USA), 2 mM L-glutamine (Gibco-BRL, San Francisco, California, USA) with added penicillin and streptomycin (Gibco-BRL) and 10% FBS (Hyclone) in the presence of 10 ng/mL IL-7 (Peprotech, Rocky Hill, New Jersey, USA) and 10 ng/mL 1 L-15 (Peprotech). We cotransduced CLL-1 CAR with a gammaretroviral vector SFG encoding the human IL15 gene linked via a 2A sequence8 (link) with the inducible caspase-9 (iC9) suicide gene that induces apoptosis on specific binding with a small molecule chemical inducer of dimerization (CID) AP20187 (Takara Bio, California, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!